EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Highly Brominated Quinolines: Synthesis, Characterization, and Investigation of Anticancer Activities Supported by Molecular Dynamics

Osman Çakmak, Salih Ökten iD, Tuğba Kul Köprülü, Cenk A Andac, Şaban Tekin, Seyfullah Oktay Arslan

Chemical Biology & Drug Design · 2025-05 · 105 (5)

DOI: 10.1111/cbdd.70120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 06.05.2025. Verfasst von Osman Çakmak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastronomy, Faculty of Arts, Design and Architecture, Istanbul Rumeli University, Silivri, Istanbul, Turkey. Hauptthemen laut MEDLINE: Quinolines, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we synthesized and characterized novel brominated methoxyquinolines ( 7 and 11 ) and nitrated bromoquinoline ( 17 ) derivatives with potential antiproliferative activity against cancer cell lines. Starting from 1,2,3,4‐tetrahydroquinoline (THQ, 1 ), a series of brominated quinoline compounds was obtained via regioselective bromination and subsequent reactions. The structure of the key compound, 3,5,6,7‐tetrabromo‐8‐methoxyquinoline ( 7 ), was confirmed using 1D and 2D NMR techniques. Additionally, unexpected bromination of 3,6,8‐trimethoxyquinoline ( 5 ) yielded 5,7‐dibromo‐3,6‐dimethoxy‐8‐hydroxyquinoline ( 11 ), allowing functionalization of both rings in the quinoline. The direct nitration of 6,8‐dibromoquinoline ( 6 ) yielded the corresponding 5‐nitro derivative ( 17 ), a precursor to amino derivatives that activate the bromine group on the ring. Antiproliferative activities of these derivatives ( 7 , 11 , 17 ) were assessed against C6, HeLa, and HT29 cancer cell lines using the BCPE assay. Compounds 7 , 11 , and 17 exhibited significant inhibitory effects, with compound 11 showing the highest activity (IC 50 values of 5.45–9.6 μg/mL). Furthermore, the cytotoxicity of these compounds was evaluated using the LDH assay, indicating lower cytotoxic effects compared to the control drug 5‐FU. The ability of compounds 11 and 17 to induce apoptosis was confirmed through DNA laddering, while compound 7 showed no such effect. Compounds 7 and 11 inhibited human topoisomerase I, a critical enzyme for DNA replication and repair, with significant binding energies determined by MM‐PBSA studies. The wound healing assay demonstrated that compound 17 effectively inhibited the migration of HT29 cells. These findings highlight the potential of these novel quinoline derivatives as effective anticancer agents, warranting further investigation into their mechanisms of action and therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesAntineoplastic AgentsHumansCell Line, TumorMolecular Dynamics SimulationCell ProliferationHalogenationDNA Topoisomerases, Type IApoptosisDrug Screening Assays, AntitumorStructure-Activity Relationship

Stichwörter der Autor:innen

antiproliferative activityapoptotic profilesbrominated methoxy quinolinescancer drug candidatescytotoxicityfunctionalizationmolecular dynamicnitrationregioselective route

Substanzen

QuinolinesAntineoplastic AgentsDNA Topoisomerases, Type I

Autor:innen und Institutionen

  • Department of Gastronomy, Faculty of Arts, Design and Architecture, Istanbul Rumeli University, Silivri, Istanbul, Turkey.
  • Department of Maths and Science Education, Faculty of Education, Kırıkkale University, Yahşihan, Kırıkkale, Turkey.
  • Hamidiye Vocational School of Health Services, Department of Medical Services and Techniques, Medical Laboratory Techniques, University of Health Sciences, Üsküdar, Istanbul, Turkey.
  • Department of Medical Pharmacology, School of Medicine, Yeditepe University, Ataşehir, Istanbul, Turkey.
  • Hamidiye Faculty of Medicine, Department of Basic Medical Sciences, Medical Biology, University of Health Sciences, Üsküdar, Istanbul, Turkey.
  • Department of Medical Pharmacology, School of Medicine, Ankara Yıldırım Beyazıt University, Çankaya, Ankara, Turkey.

ORCID-Profile: Salih Ökten

Zitieren

APA

Çakmak, O., Ökten, S., Köprülü, T. K., Andac, C. A., Tekin, Ş., & Arslan, S. O. (2025). Highly Brominated Quinolines: Synthesis, Characterization, and Investigation of Anticancer Activities Supported by Molecular Dynamics. Chemical Biology & Drug Design, 105(5). https://doi.org/10.1111/cbdd.70120

Vancouver

Çakmak O, Ökten S, Köprülü TK, Andac CA, Tekin Ş, Arslan SO. Highly Brominated Quinolines: Synthesis, Characterization, and Investigation of Anticancer Activities Supported by Molecular Dynamics. Chemical Biology & Drug Design. 2025;105(5). doi:10.1111/cbdd.70120

BibTeX
@article{akmak2025,
  author = {Çakmak, Osman and Ökten, Salih and Köprülü, Tuğba Kul and Andac, Cenk A and Tekin, Şaban and Arslan, Seyfullah Oktay},
  title = {Highly Brominated Quinolines: Synthesis, Characterization, and Investigation of Anticancer Activities Supported by Molecular Dynamics},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  volume = {105},
  number = {5},
  doi = {10.1111/cbdd.70120}
}
Kostenlos starten →